Browse studies

Find your next paid study

499 recruiting studies matching your filters

Discrete Choice Experiments for HIV Prevention in Atlanta Adolescents- Atlanta

This study applies Social Cognitive Theory to develop behavioral interventions promoting PrEP adherence. It seeks to adapt and test the enhanced HMP app for fe…

HIV Infections

Estimated

~$10 – $6,250

Emory UniversityNCT07535346

Validation of Diagnostic Codes for Identifying Chlamydial Infections From TriNetX Electronic Health Record Data in the United States

This study is a pharmacoepidemiologic method study based on the secondary use of pre-existing data that examines whether TriNetX, a global health research netw…

Chlamydial Infections

Estimated

~$10 – $1,125

SanofiNCT07094373

Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

Objective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less th…

HTLV-I InfectionTropical Spastic Paraparesis

Estimated

~$10 – $675

National Institute of Neurological Disorders and Stroke (NINDS)NCT00001778

Observational

Evaluating the Camino Intervention to Reduce HIV Risk and Poor Care Outcomes Among Latin Americans

The Camino Study evaluates a status-neutral, multi-level pilot intervention designed to improve HIV prevention and care engagement among Latin Americans with u…

HIV Infections

Estimated

~$10 – $6,250

American UniversityNCT07834853

Observational

The TAIL-PrEP Study: Acceptability and Feasibility of a Tailored Adherence Intervention for Safe Discontinuation of Long-acting PrEP

The goal of the TAIL-PrEP study is to understand how to support the safe discontinuation of injectable long-acting cabotegravir (cab-LA) and lenacapavir (LEN) …

HIV Infections

Estimated

~$10 – $6,250

Columbia UniversityNCT06868641

Phase 2

A Phase 2/3, Randomized, Active-Controlled, Open-Label (Phase 2) and Double-Blind (Phase 3) Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Once Daily in Treatment-Naïve Adult Participants Living With HIV-1

Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1). The usual (standard) treatment for HIV-1 is antiretroviral therapy (…

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07266831

Phase 2

RETAIN: A Phase 2/3 Randomized, Placebo-Controlled Study to Evaluate the Efficacy of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Total Knee Arthroplasty (TKA)

The goal of this clinical trial is to evaluate whether the investigational drug PLG0206 can help reduce recurrence of infection in adults who have undergone to…

Prosthetic-joint Infection

Estimated

~$10 – $7,500

PeptilogicsNCT07214311

18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis: A Prospective Multicenter Study of Diagnostic Accuracy

Diabetic foot osteomyelitis (DFO) is a bone infection of the foot that can occur in people with diabetes and may lead to serious complications, including amput…

Diabetic Foot Infections

Estimated

~$10 – $750

Jewish General HospitalNCT07828691

Vonoprazan Pregnancy Registry: An Observational Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

The main objective of the study is to compare the maternal, fetal, and infant outcomes of pregnant women who are exposed to vonoprazan during pregnancy with ou…

Erosive EsophagitisHeartburnSymptomatic Non-erosive Gastroesophageal Reflux Disease+1 more

Estimated

~$10 – $1,050

Phathom Pharmaceuticals, Inc.NCT06660342

Phase 1

A Phase 1 Open-label, Non-randomized, Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged …

HIV Infections

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT06665646

Observational

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severit…

Substance UseHIV Infections

Estimated

~$10 – $6,250

Hunter College of City University of New YorkNCT06307977

Phase 4

Longitudinal Serum and Mucosal RSV Antibodies Following Clesrovimab (Enflonsia™, Merck) Administration in Infants During Their First Respiratory Season or [The EMBRACE Study: Enflonsia™ Monoclonal in Babies - RSV Antibody Concentration Evaluation]

Clesrovimab is an FDA-approved antibody drug recommended for infants younger than 8 months who are entering their first respiratory syncytial virus (RSV) seaso…

RSV Infection

Estimated

~$10 – $6,250

Emory UniversityNCT07824167